What shareholders can do to beat the market with Iovance Biotherapeutics Inc. (IOVA) stock

As of close of business last night, Iovance Biotherapeutics Inc.’s stock clocked out at $7.69, up 9.86% from its previous closing price of $7.00. In other words, the price has increased by $+0.69 from its previous closing price. On the day, 19657307 shares were traded. IOVA stock price reached its highest trading level at $7.86 during the session, while it also had its lowest trading level at $6.86.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

To gain a deeper understanding of IOVA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.70 and its Current Ratio is at 4.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on December 09, 2022, Downgraded its rating to Neutral and sets its target price to $6 from $20 previously.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 21 when MCPEAK MERRILL A bought 10,000 shares for $6.15 per share. The transaction valued at 61,500 led to the insider holds 70,150 shares of the business.

Rothbaum Wayne P. bought 10,000,000 shares of IOVA for $65,000,000 on Dec 02. The Director now owns 18,067,333 shares after completing the transaction at $6.50 per share. On Nov 29, another insider, MCPEAK MERRILL A, who serves as the Director of the company, bought 10,000 shares for $6.31 each. As a result, the insider paid 63,100 and bolstered with 238,633 shares of the company.

Stock Price History:

Over the past 52 weeks, IOVA has reached a high of $18.73, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is 6.63, while the 200-Day Moving Average is calculated to be 10.40.

Shares Statistics:

It appears that IOVA traded 4.36M shares on average per day over the past three months and 3.98M shares per day over the past ten days. A total of 157.82M shares are outstanding, with a floating share count of 146.85M. Shares short for IOVA as of Oct 13, 2022 were 18.17M with a Short Ratio of 21.70M, compared to 19.54M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 11.51% and a Short% of Float of 12.10%.

Earnings Estimates

As of right now, 14 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.64 for the current quarter, with a high estimate of -$0.56 and a low estimate of -$0.7, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.66, with high estimates of -$0.52 and low estimates of -$0.9.

Analysts are recommending an EPS of between -$2.29 and -$2.8 for the fiscal current year, implying an average EPS of -$2.51. EPS for the following year is -$2.41, with 13 analysts recommending between -$1.9 and -$3.15.